BSMS > About BSMS > Contact us > Staff > Dr Chi Eziefula

Dr Chi Eziefula

Dr Chi Eziefula (MBBS MA MRCP FRCPath)

Associate Professor in Infection
E: c.eziefula@bsms.ac.uk
T: +44 (0)1273 872700
Location: Ground Floor, BSMS Medical Research Building, University of Sussex, Falmer, Brighton, BN1 9PX

DA: Debbie Miller
E: d.miller@bsms.ac.uk
T: +44(0)1273 877889

Area of expertise: Menstrual Health, Women’s Health, Malaria epidemiology, Clinical Epidemiology, Clinical trials, Infectious diseases, Microbiology, Tropical medicine

Research areas: Menstrual Health, Health Justice, Environmental Sustainability, Women’s Health, Epidemiology, Malaria Transmission-Blocking, Malaria Elimination, Falciparum Malaria, Migrant Health, Global Health

Other relevant positions: Co-Director of Centre for Cultures of Reproduction, Technologies and Health. Fellow of the Sussex Sustainability Research Programme. Theme leader for Infection and Immunity module 101

ORCID ID: https://orcid.org/0000-0003-3616-9513 >

Biography

Dr Chi Eziefula is an Associate Professor in Infection at Brighton and Sussex Medical School and an Honorary Consultant in Infectious Diseases and Microbiology at University Hospitals Sussex NHS Trust. She is co-director of CORTH, Centre for Cultures of Reproduction, Technologies and Health at the University of Sussex.

Chi combines hands on clinical care In Infection, Tropical Medicine and Medical Microbiology with Global Health and Women’s Health research.

Her global health expertise has been supported by Wellcome Trust-funded research positions in Kenya, (Kilifi, KEMRI/ Wellcome Trust Research Programme), and Uganda (Bloomsbury Wellcome Trust Clinical PhD Programme in International Health).

She is a Fellow of the Sussex Sustainability Research Programme.

Research

Chi has worked in the field of malaria research since 2005. Her doctoral work at the London School of Hygiene and Tropical Medicine evaluated a pharmacological intervention to block transmission of falciparum malaria in Uganda, conducting the first dose-finding trial for primaquine as a gametocytocidal agent, which contributed to a change in the World Health Organisation malaria treatment guidelines. Her wider research interests include Menstrual Health and Global Women’s Health.

Her work in Menstrual Health includes the establishment of an international research network exploring Menstrual Health, human rights and environmental sustainability in Uganda, Sudan and Kenya and the UK. She supports conversation and learning on the topic of menstrual health across Schools at the University of Sussex, and publicly, giving talks and holding workshops. Her current work explores how to represent young menstruators' needs through citizen science. She is part of the Period Dignity Project at Sussex, supporting access to menstrual products and developing the approach to menstrual health policy.

Teaching

Chi teaches Infectious Diseases, Microbiology and Clinical and Tropical Medicine to undergraduates and post-graduate doctors. She leads the Infection and Immunity theme for first year medical students. She teaches on the Scientific Basis of Infectious Diseases module at BSMS and gives bedside and small group clinical teaching and laboratory-based clinical microbiology teaching to fourth year students. She has taught, examined and been an exam board member on the Diploma in Tropical Medicine and Hygiene at the London School of Hygiene and Tropical Medicine. She teaches Masters Modules in Global Health and Clinical Medicine at BSMS.

Selected publications

Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis,The Journal of Infectious Diseases, Volume 225, Issue 7, 1 April 2022, Pages 1215–1226, https://doi.org/10.1093/infdis/jiaa498

Stoneham SM, Milne KM, Nuttal E, Frew GH, Sturrock BR, Sivaloganathan H, Ladikou EE, Drage S, Phillips B, Chevassut TJT, et al. Thrombotic risk in COVID-19: a case series and case–control study, Clinical Medicine 18 May 2020 (Article)

Pett H, Bradley J, Okebe J, Dicko A, Tiono AB, Gonçalves BP, Stone W, Chen I, Lanke K, Neuvonen M, et al. CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum, Antimicrobial Agents and Chemotherapy 63(10) 01 Jan 2019 (Article)

Finnerty F, George S, Eziefula AC. The health of recent migrants from resource-poor countries, Medicine (United Kingdom) 46(1):66-71 01 Jan 2018 (Article)

Artesunate-mefloquine: a malaria treatment for African children? Eziefula AC. Lancet Infect Dis. 2016 Oct;16(10):1086-1087. doi: 10.1016/S1473-3099(16)30125-6. Epub 2016 Jul 16. No abstract available. PMID: 27430373

Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine. Eziefula AC, Pett H, Grignard L, Opus S, Kiggundu M, Kamya MR, Yeung S, Staedke SG, Bousema T, Drakeley C. Antimicrob Agents Chemother. 2014 Aug;58(8):4971-3. doi: 10.1128/AAC.02889-14. Epub 2014 Jun 9. PMID: 24913169

Low-dose primaquine for falciparum malaria. Bousema T, Eziefula AC, Pett H, Drakeley C. Lancet Infect Dis. 2014 Aug;14(8):677. doi: 10.1016/S1473-3099(14)70842-4. No abstract available. PMID: 25056018

Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda. Chang HH, Meibalan E, Zelin J, Daniels R, Eziefula AC, Meyer EC, Tadesse F, Grignard L, Joice RC, Drakeley C, Wirth DF, Volkman SK, Buckee C, Bousema T, Marti M. Sci Rep. 2016 May 20;6:26330. doi: 10.1038/srep26330. PMID: 27197604

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial. Gonçalves BP, Tiono AB, Ouédraogo A, Guelbéogo WM, Bradley J, Nebie I, Siaka D, Lanke K, Eziefula AC, Diarra A, Pett H, Bougouma EC, Sirima SB, Drakeley C, Bousema T. BMC Med. 2016 Mar 8;14:40. doi: 10.1186/s12916-016-0581-y. PMID: 26952094

Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Eziefula AC, Bousema T, Yeung S, Kamya M, Owaraganise A, Gabagaya G, Bradley J, Grignard L, Lanke KH, Wanzira H, Mpimbaza A, Nsobya S, White NJ, Webb EL, Staedke SG, Drakeley C. Lancet Infect Dis. 2014 Feb;14(2):130-9. doi: 10.1016/S1473-3099(13)70268-8. Epub 2013 Nov 13. PMID: 24239324

CLICK HERE TO elements profile >